| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Gene Therapy |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
100M | 93.91% |
| Gene Therapy |
Pre-Revenue Gene Editing Pharmaceuticals
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
4.77M | 4.48% |
| Gene Therapy |
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
1.72M | 1.61% |
| keyboard_arrow_down |
Gene Therapy
Pharmaceutical Patent Licensing
|
100M | 93.91% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Gene Therapy
Pre-Revenue Gene Editing Pharmaceuticals
|
4.77M | 4.48% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Gene Therapy
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
|
1.72M | 1.61% |
| keyboard_arrow_right |
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
||